Mirae Asset Global Etfs Holdings »

Karyopharm Therapeutics shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $90k 9.2k 9.77

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Apple (AAPL)
Cameco Corporation (CCJ)
Global X Fds Russell 2000 Etf (RSSL)
Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Wheaton Precious Metals Corp (WPM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics